Reporting Quality of Oral TCM Systematic Reviews Based on the PRISMA Harms Checklist from 2013 to 2020

Author:

Chang Tianying1ORCID,Cui Yingzi1,Zhang Ying2,Ma Jinhui3,Tan Jing4ORCID,Wang Jian2ORCID

Affiliation:

1. EBM Office, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China

2. Neurology Department, The Affiliated Hospital to Changchun University of Chinese Medicine, Changchun 130021, China

3. Department of Health Research, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

4. Chinese Evidence-Based Medicine Center and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan 610041, China

Abstract

Background. Systematic reviews focusing on the effectiveness of different kinds of healthcare interventions have been widely published, but there were few guidelines for reporting safety concerns before 2016. The PRISMA harms checklist, which was published in 2016, can standardize reporting quality. Objectives. To evaluate the safety information reporting quality of oral traditional Chinese medicine (TCM) in systematic reviews before and after the PRISMA harms checklist was published and to explore factors associated with better reporting. Methods. We searched PubMed, the Cochrane Library, and Embase to identify all systematic reviews using oral TCM as interventions published before (from 2013 to 2015) and after (from 2017 to 2020) the PRISMA harms checklist was published. We used the PRISMA harms checklist to assess the quality of reporting of the safety information to included systematic reviews. Results. In total, 200 systematic reviews were sampled from eligible studies published between 2013 and 2020. Reviews from 2016 were excluded. Scores on the PRISMA harms checklist (23 items) ranged from 0 to 12. A systematic reviews published after 2016 had better reporting quality compared with studies published before 2016 with regard to the title ( P = 0.03 ), results of individual studies ( P = 0.016 ), and risk of bias across studies ( P = 0.043 ). In all included systematic reviews of our study, the state conclusion in coherence with review findings was reported adequately with the proportion of adherence at 95%; other items had a reporting proportion ranging from 0% to 57%. The four essential reporting items of the PRISMA harms checklist also had a low reporting quality ranging from 0% to 4%. Conclusions. Oral TCM systematic reviews reported inadequate safety information before and after the PRISMA harms checklist was published. This survey suggested that the PRISMA harms checklist should be recommended more to both original research and systematic review authors.

Funder

National TCM Evidence-Based Capacity Building Project

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

Reference32 articles.

1. Using Traditional Chinese Medicine to Relieve Asthma Symptoms: A Systematic Review and Meta-Analysis

2. PRISMA harms checklist: improving harms reporting in systematic reviews

3. The methodological and reporting quality of systematic reviews from China and the USA are similar

4. Development and current situation analysis of Chinese medicine systematic reviews/meta analysis of 19 years;J. Y. Wang;Journal of Traditional Chinese Medicine,2017

5. Current status in the field of traditional Chinese medicine: a systematic review and meta- analysis;H. Y. Sun;Hebei Journal of Traditional Chinese Medicine,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3